IFNG and melanoma: In line with these findings, Ji et al. reported that melanoma lesions responding to ipilimumab (anti-CTLA-4) displayed a greater on-treatment increase in transcripts consistent with an interferon gamma (IFN-γ) induced T cell cytotoxic response compared to non-responding ones [26].